McLane Co. plans to acquire Meadowbrook Meat Co. (MBM), a national foodservice distributor. Financial terms of the deal weren’t disclosed. McLane chief executive officer Grady Rosier stated Thursday that the acquisition expands McLane’s portfolio of companies in the food and beverage industries.
Taro Pharmaceutical Industries Ltd. has given a thumbs-down to an unsolicited buyout proposal by Sun Pharmaceutical Industries Ltd. Taro said Thursday that a special committee of its board unanimously rejected the Oct.
Not Your Mother’s hair care plans to donate 10% of all of its online sales during October to the Young Survival Coalition (YSC) in recognition of Breast Cancer Awareness Month. The company said that in addition to the donation through business on its nymbrands.
Dr. Reddy’s Laboratories has shipped atorvastatin calcium tablets, a medication for high cholesterol, in the U.S. market.
Cynosure Inc. has received approval from the Food and Drug Administration for an over-the-counter device, developed with Unilever, to treat facial wrinkles.
VIVUS Inc. has been cleared by the Food and Drug Administration to market Qsymia, a weight-loss pill aimed at adults struggling with obesity and related health conditions.
Jeffrey Farber, vice chairman at Lannett Co., has been named chairman, succeeding Ronald West. The generic drug maker said Monday that Farber takes over the chairman’s post effective immediately.
Karma Culture LLC has made its Karma Wellness Water available at drug store, supermarket and convenience store chains nationwide.
Par Pharmaceutical Cos. has agreed to be acquired by private equity firm TPG in a deal valued at $1.9 billion. The generic drug and specialty pharmaceutical company said Monday that under the agreement, Par can solicit proposals from other parties until Aug. 24, and its board plans to do so. If
Sanofi Pasteur has begun shipping the first lots of Fluzone vaccine to U.S. health care providers with the Food and Drug Administration’s licensing of the 2012-13 formulation.
GlaxoSmithKline plans to acquire Human Genome Sciences (HGS) in a cash deal of about $3 billion. GSK said Monday that the purchase of HGS will give the company full ownership of the medications Benlysta (lupus), albiglutide (type 2 diabetes) and darapladib (coronary heart disease).
Par Formulations Private Ltd., a subsidary of Par Pharmaceutical Cos., has received its first Abbreviated New Drug Application (ANDA) approval from the Food and Drug Administration. The company said Friday that Par Formulations, formerly Edict Pharmaceuticals Private Ltd.
Watson Pharmaceuticals Inc. is set to release Next Choice ONE DOSE (levonorgestrel 1.5 mg), an emergency contraceptive pill. The company said Friday that its Watson Laboratories Inc.
GE Lighting recently helped Walgreen Co. upgrade general lighting across 80% of the chain’s drug store locations nationwide. GE said Thursday that when consumers walk the aisles their local Walgreens store, they will notics the difference from the new lighting.
Original Gourmet Food Co. has announced its support for the National Breast Cancer Foundation and its battle against breast cancer.
This month, Reckitt Benckiser is rolling out a trio of new cough/cold products.
